MICROBIAL INHIBITORS OF ANGIOTENSIN-CONVERTING-ENZYME

被引：0
|
作者：
SANGER, J
REISSMANN, S
机构：
来源：
PHARMAZIE | 1987年 / 42卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
引用
收藏
页码：212 / 212
页数：1
相关论文
共 50 条
  • [41] A comparison of outcomes with angiotensin-converting-enzyme inhibitors and diuretics for hypertension in the elderly
    Wing, LMH
    Reid, CM
    Ryan, P
    Beilin, LJ
    Brown, MA
    Jennings, GLR
    Johnston, CI
    McNeil, JJ
    Macdonald, GJ
    Marley, JE
    Morgan, TO
    West, MJ
    Nelson, M
    Bruce, A
    Beckinsale, P
    Thompson, J
    McMurchie, M
    Fraser, G
    Gleave, D
    Cope, V
    DeLooze, F
    Moore, S
    Dibben, C
    Newbury, J
    Miles, H
    McDermott, B
    Willson, K
    Bear, C
    West, M
    Harrap, S
    Johnston, C
    Beilin, L
    Ryan, P
    Wing, L
    Reid, C
    Beilin, L
    Brown, M
    Ryan, P
    Wing, L
    Reid, C
    Jennings, G
    Fletcher, P
    Feneley, M
    Dewar, E
    Wing, L
    Reid, C
    McNeil, J
    Wing, L
    Marley, J
    Reid, C
    NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (07): : 583 - 592
  • [42] Angiotensin-converting-enzyme inhibitors for impaired glucose tolerance - Is there still hope?
    Ingelfinger, Julie R.
    Solomon, Caren G.
    NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (15): : 1608 - 1610
  • [43] Angiotensin-converting-enzyme Inhibitors in Treatment of Atherosclerotic Peripheral Arterial Disease
    I.A.SUCHKOV
    R.E.KALININ
    宁夏医科大学学报, 2013, 35 (07) : 733 - 737+724
  • [44] Compliance with and dosing of angiotensin-converting-enzyme inhibitors before and after hospitalization
    Roe, CM
    Motheral, BR
    Teitelbaum, F
    Rich, MW
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2000, 57 (02) : 139 - 145
  • [45] Aortic valvular heart disease: is there a place for angiotensin-converting-enzyme inhibitors?
    Elder, Douglas H. J.
    McAlpine-Scott, Victoria
    Choy, Anna Maria
    Struthers, Allan D.
    Lang, Chim C.
    EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2013, 11 (01) : 107 - 114
  • [46] Angiotensin-converting-enzyme inhibitors in the management of cardiac failure: Are we ignoring the evidence?
    Hillis, GS
    Trent, RJ
    Winton, P
    MacLeod, AM
    Jennings, KP
    QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 1996, 89 (02) : 145 - 150
  • [47] Angioedema may not be a class side-effect of the angiotensin-converting-enzyme inhibitors
    Karagiannis, A
    Pyrpasopoulou, A
    Tziomalos, K
    Florentin, M
    Athyros, V
    QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2006, 99 (03) : 197 - 198
  • [48] RISK OF HYPOTENSION IN THE TREATMENT OF HEART-FAILURE WITH ANGIOTENSIN-CONVERTING-ENZYME INHIBITORS
    OSTERZIEL, KJ
    DIETZ, R
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1993, 118 (03) : 65 - 68
  • [49] Penile angioedema associated with the use of angiotensin-converting-enzyme inhibitors and angiotensin II receptor blockers
    McCabe, John
    Stork, Christine
    Mailloux, Danielle
    Su, Mark
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2008, 65 (05) : 420 - 421
  • [50] Drug insight:: angiotensin-converting-enzyme inhibitors and atrial fibrillation -: indications and contraindications
    Lévy, S
    NATURE CLINICAL PRACTICE CARDIOVASCULAR MEDICINE, 2006, 3 (04): : 220 - 225
12345